FI781753A7 - Nya ftalazinderivat - Google Patents

Nya ftalazinderivat Download PDF

Info

Publication number
FI781753A7
FI781753A7 FI781753A FI781753A FI781753A7 FI 781753 A7 FI781753 A7 FI 781753A7 FI 781753 A FI781753 A FI 781753A FI 781753 A FI781753 A FI 781753A FI 781753 A7 FI781753 A7 FI 781753A7
Authority
FI
Finland
Prior art keywords
phthalazinder
ribs
new
phthalazinder ribs
new phthalazinder
Prior art date
Application number
FI781753A
Other languages
English (en)
Finnish (fi)
Inventor
Simon Fraser Campbell
John Christopher Danilewicz
Anthony Garth Evans
Allan Leslie Ham
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI781753A7 publication Critical patent/FI781753A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI781753A 1977-06-03 1978-06-01 Nya ftalazinderivat FI781753A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2358277 1977-06-03

Publications (1)

Publication Number Publication Date
FI781753A7 true FI781753A7 (fi) 1978-12-04

Family

ID=10198020

Family Applications (1)

Application Number Title Priority Date Filing Date
FI781753A FI781753A7 (fi) 1977-06-03 1978-06-01 Nya ftalazinderivat

Country Status (29)

Country Link
US (1) US4289772A (cs)
JP (1) JPS5416488A (cs)
AR (2) AR222013A1 (cs)
AT (2) AT362792B (cs)
AU (1) AU505373B1 (cs)
BE (1) BE867727A (cs)
CA (1) CA1111850A (cs)
DD (1) DD137355A5 (cs)
DE (1) DE2824064A1 (cs)
DK (1) DK248078A (cs)
EG (1) EG13527A (cs)
ES (4) ES470470A1 (cs)
FI (1) FI781753A7 (cs)
FR (1) FR2392986A1 (cs)
GB (1) GB2000136B (cs)
GR (1) GR74402B (cs)
HU (1) HU179745B (cs)
IL (1) IL54842A (cs)
IN (3) IN148482B (cs)
IT (1) IT1094944B (cs)
LU (1) LU79761A1 (cs)
NL (1) NL7806016A (cs)
NO (1) NO781935L (cs)
NZ (1) NZ187453A (cs)
PL (3) PL116437B1 (cs)
PT (1) PT68126A (cs)
SE (1) SE7806519L (cs)
SU (2) SU856383A3 (cs)
ZA (1) ZA783183B (cs)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370328A (en) * 1977-11-03 1983-01-25 Pfizer Inc. Cardiac stimulant 1-(3- or 4-substituted piperidino)phthalazines
IL59619A0 (en) * 1979-03-28 1980-06-30 Pfizer Phthalazine derivatives,their preparation and pharmaceutical compositions containing them
PL128409B1 (en) * 1980-03-01 1984-01-31 Wyeth John & Brother Ltd Process for preparing novel derivatives of piperidine
GB8320958D0 (en) * 1983-08-03 1983-09-07 Pfizer Ltd Quinazoline cardiac stimulants
US5001125A (en) * 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines
US4882354A (en) * 1987-12-16 1989-11-21 Norwich Eaton Pharmaceuticals, Inc. N-hydroxy-5-phenyl-2-furancarboximidamides useful as cardiotonic agents
JP3169188B2 (ja) 1991-01-31 2001-05-21 杏林製薬株式会社 カルバミン酸誘導体及びその製造方法
US5300515A (en) * 1991-01-31 1994-04-05 Kyorin Pharmaceutical Co., Ltd. Carbamic acid derivatives and method for preparing the same
EP0621267A1 (en) * 1993-04-07 1994-10-26 Shell Internationale Researchmaatschappij B.V. Spiropiperidine derivatives and their use as fungicides
AU5772196A (en) * 1995-05-19 1996-11-29 Chiroscience Limited 3,4-disubstituted-phenylsulphonamides and their therapeutic use
NZ333354A (en) * 1996-08-20 2000-05-26 Eisai Co Ltd Fused pyridazine compounds for erectile dysfunction
US20030186963A1 (en) 2001-09-14 2003-10-02 Dorwald Florencio Zaragoza Substituted piperidines
US20040224986A1 (en) * 2002-08-16 2004-11-11 Bart De Corte Piperidinyl targeting compounds that selectively bind integrins
AU2003259891A1 (en) * 2002-08-16 2004-03-19 Janssen Pharmaceutica N.V. Piperidinyl compounds that selectively bind integrins
US20060019975A1 (en) * 2004-07-23 2006-01-26 Pfizer Inc Novel piperidyl derivatives of quinazoline and isoquinoline
TW200630337A (en) 2004-10-14 2006-09-01 Euro Celtique Sa Piperidinyl compounds and the use thereof
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス，インコーポレイティド ムスカリン性受容体調節による神経発生
EP2377530A3 (en) 2005-10-21 2012-06-20 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
BRPI0707223A2 (pt) * 2006-01-27 2011-04-26 Pfizer Prod Inc compostos de derivados de aminoftalazina
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US8247442B2 (en) 2006-03-29 2012-08-21 Purdue Pharma L.P. Benzenesulfonamide compounds and their use
TW200815353A (en) 2006-04-13 2008-04-01 Euro Celtique Sa Benzenesulfonamide compounds and their use
WO2007118854A1 (en) 2006-04-13 2007-10-25 Euro-Celtique S.A. Benzenesulfonamide compounds and the use thereof
AU2007249435A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 HT receptor mediated neurogenesis
JP2009536669A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド アンジオテンシン調節による神経新生
EP1900731A1 (de) * 2006-09-07 2008-03-19 Bayer Schering Pharma Aktiengesellschaft N-(1-Phthalazin-1-yl-piperidin-4-yl)-amide als EP2-Rezeptor Modulatoren
EP1903037A1 (de) * 2006-09-07 2008-03-26 Bayer Schering Pharma Aktiengesellschaft 1-(Het)aryl-3-[hetaryl-piperidin-4-yl]-thioharnstoffe als Modulatoren des EP2-Rezeptors
AU2007292848A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2008124118A1 (en) 2007-04-09 2008-10-16 Purdue Pharma L.P. Benzenesulfonyl compounds and the use therof
JP2010535733A (ja) 2007-08-07 2010-11-25 エフ．ホフマン−ラ ロシュ アーゲー Ｎｋ３受容体アンタゴニストとしてのピロリジンアリールエーテル
ES2369955T3 (es) 2007-08-22 2011-12-09 F. Hoffmann-La Roche Ag Pirrolidina-aril-éteres como antagonistas de receptores de nk3.
MX2010002585A (es) * 2007-09-14 2010-03-26 Hoffmann La Roche Derivados de piperidina como antagonistas del receptor nk3.
US8765736B2 (en) 2007-09-28 2014-07-01 Purdue Pharma L.P. Benzenesulfonamide compounds and the use thereof
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
AR077014A1 (es) 2009-06-19 2011-07-27 Lilly Co Eli Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer
US20150119399A1 (en) 2012-01-10 2015-04-30 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
CA3198661A1 (en) 2020-10-13 2022-04-21 Endeavor Biomedicines, Inc. Methods of treating fibrosis
CN113087654B (zh) * 2021-04-15 2022-12-23 苏州昊帆生物股份有限公司 哌啶-4-丁胺的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1094044A (en) * 1965-07-12 1967-12-06 Vantorex Ltd Phthalazine derivatives
GB1199768A (en) 1966-10-31 1970-07-22 Pfizer & Co C Nitrogen Heterocycles and process for their preparation
GB1293565A (en) 1969-05-03 1972-10-18 Aspro Nicholas Ltd Aminophthalazines and pharmaceutical compositions thereof
GB1460389A (en) 1974-07-25 1977-01-06 Pfizer Ltd 4-substituted quinazoline cardiac stimulants

Also Published As

Publication number Publication date
FR2392986A1 (fr) 1978-12-29
IL54842A0 (en) 1978-08-31
IL54842A (en) 1982-01-31
NZ187453A (en) 1980-12-19
FR2392986B1 (cs) 1982-07-16
BE867727A (fr) 1978-12-01
PL113208B1 (en) 1980-11-29
ATA400878A (de) 1980-11-15
AR222013A1 (es) 1981-04-15
IT1094944B (it) 1985-08-10
JPS5538351B2 (cs) 1980-10-03
AU505373B1 (en) 1979-11-15
US4289772A (en) 1981-09-15
NL7806016A (nl) 1978-12-05
IN148482B (cs) 1981-03-07
JPS5416488A (en) 1979-02-07
DK248078A (da) 1978-12-04
DE2824064A1 (de) 1978-12-14
ATA305080A (de) 1980-12-15
HU179745B (en) 1982-12-28
NO781935L (no) 1978-12-05
EG13527A (en) 1981-12-31
AT363096B (de) 1981-07-10
ES478199A1 (es) 1980-01-16
GB2000136B (en) 1982-01-06
LU79761A1 (fr) 1980-01-22
AR223999A1 (es) 1981-10-15
PL116437B1 (en) 1981-06-30
DD137355A5 (de) 1979-08-29
SU856383A3 (ru) 1981-08-15
CA1111850A (en) 1981-11-03
ZA783183B (en) 1979-06-27
SU862826A3 (ru) 1981-09-07
ES478200A1 (es) 1980-01-01
IN149973B (cs) 1982-06-19
IN149550B (cs) 1982-01-16
IT7824106A0 (it) 1978-06-01
PL116420B1 (en) 1981-06-30
ES470470A1 (es) 1979-09-01
PT68126A (en) 1978-07-01
AT362792B (de) 1981-06-10
GB2000136A (en) 1979-01-04
GR74402B (cs) 1984-06-28
ES478201A1 (es) 1980-02-01
PL207337A1 (pl) 1979-06-04
SE7806519L (sv) 1978-12-04

Similar Documents

Publication Publication Date Title
FI781753A7 (fi) Nya ftalazinderivat
FI783863A7 (fi) Stilbenderivat
FI782530A7 (fi) Nya nitroimidazoler och foerfarande foer deras framstaellning
SE7806710L (sv) Nya karbostyrilderivat
FI782931A7 (fi) Nya aemnessammansaettningar
SE7802867L (sv) Nya 4-acylamino-fenyl-etanolaminer
SE7707734L (sv) Nya hydroxi-succinimido-estrar
FI783126A7 (fi) Xantinderivat
SE7807642L (sv) Nya 1-acyl-2-cyanaziridiner
FI782481A7 (fi) Foerfarande foer framstaellning av nya organiska foereningar
FI783327A7 (fi) Foerfarande foer framstaellning av nya kemiska foereningar
SE7800739L (sv) Nya aminoalkoxifenylderivat
FI783846A7 (fi) Nya bredspektriga cefalosporinantibioter
SE7712387L (sv) Nya morfantridiner
SE7810050L (sv) Nya 7-azabensimidazoler
FI781779A7 (fi) Foerfarande foer framstaellning av nya nitroso-urinaemnen
FI780083A7 (fi) Nya ditienylalkylaminer och foerfarande foer deras framstaellning
FI772394A7 (fi) Nya behensyraestrar
SE7808018L (sv) Nya imidazo-isokinolin-dioner
FI782039A7 (fi) Nya 2-pyridyl- och 2-pyrimidylaminobensoesyror
FI782228A7 (fi) Foerfarande foer framstaellning av nya bensopyranderivat
SE7804318L (sv) Nya naftyridiner
FI781886A7 (fi) Foerfarande foer framstaellning av nya pyridazinylhydrazoner
FI780269A7 (fi) Nya ergolinderivat
FI782994A7 (fi) Foerfarande foer framstaellning av nya piperazinopyrrolobensodiazepiner

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: PFIZER CORPORATION